Compare XOMA to:
After Hours:
0.73
0.00 (0.27%) 4:04pm ET
| Last Trade: | 0.728 |
|---|---|
| Trade Time: | 3:59pm ET |
| Change: | |
| Prev Close: | 0.73 |
| Open: | 0.72 |
| Bid: | N/A |
| Ask: | 0.74 x 1000 |
| 1y Target Est: | 2.73 |
| Day's Range: | 0.72 - 0.74 |
|---|---|
| 52wk Range: | 0.37 - 1.34 |
| Volume: | 710,729 |
| Avg Vol (3m): | 3,620,680 |
| Market Cap: | 144.83M |
| P/E (ttm): | 14.27 |
| EPS (ttm): | 0.051 |
| Div & Yield: | N/A (N/A) |
| Thu, Nov 19 | XOMA LTD /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; TraEDGAR Online |
| Thu, Nov 19 | XOMA Receives NASDAQ Determination LetterGlobeNewswire |
| Wed, Nov 18 | Coverage initiated on XOMA Limited by Canaccord AdamsBriefing.com |
| Tue, Nov 17 | XOMA Appoints Jim Neal Vice President of Business DevelopmentGlobeNewswire |
| Fri, Nov 13 | Biotech Stock Mailbag: Cardium Therapeuticsat TheStreet.com |
| Fri, Nov 13 | XOMA LTD /DE/ FinancialsEDGAR Online Financials |
| Thu, Nov 12 | XOMA 052 Selected as a Top Ten Project to WatchGlobeNewswire |
| Wed, Nov 11 | XOMA Announces Presentation at Lazard Healthcare Conference on November 18GlobeNewswire |
| Mon, Nov 9 | XOMA LTD /DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Mon, Nov 9 | Doc Offers Top Hep C Drug Picks: BioBuzzat TheStreet.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.